Thanks for posting this presentation. It really makes the point (Dr James has posted it separately) that from the broader population's perspective treatment rate is more important than the SVR rate. It also notes that treatment should move out of speciality clinics which would assist in more people accessing the treatment which reminded me.....
I have recently relocated to the Queensland coast. The other day I went to see a GP who I had visited once a few years ago who was aware of my previous HepC status. She was delighted with my news and said that she was now able to prescribe the HepC medication (although she was not fully conversant yet with it all - so I told her to visit this site!). She's a clever and compassionate doctor and I was happy (to the point of tears!) that she would now be in the position to help more people.
G1a probably early 1980's, Biopsy F1(2010), F2-F3(2015). VL 5+mill; 2+mill (2014) Tx naive. Accessed Sof/Led through Dr Freeman at GP2U and Buyers Club (lifesavers!!!)
Commenced tx 12/11/15. 9 wk: VL <15 Detected but LFT = Normal 12 week results: UND (Yay!) Due to slow response commenced Sof/Dac 4 Feb for 12 weeks. EOT @ 24 weeks 27 April 2016. (With thanks to Dr Freeman et al). SVR11 result: VL 1,950,000. It's back!
New tx 030916 (Viekira Pak, Solvadi, Ribavirin UND @ 111116. EOT 170217.
SVR12 and SVR 24
